Featured Research

from universities, journals, and other organizations

Placebo, Antidepressant May Lift Depression Via Common Mechanism

Date:
May 2, 2002
Source:
NIH/National Institute Of Mental Health
Summary:
Whether it's a widely prescribed medication or a placebo, a successful treatment for depression must trigger a common pattern of brain activity changes, suggests a team of researchers funded by the National Institute of Mental Health.

Whether it's a widely prescribed medication or a placebo, a successful treatment for depression must trigger a common pattern of brain activity changes, suggests a team of researchers funded by the National Institute of Mental Health.

Using functional brain imaging, Helen Mayberg, M.D., and colleagues at the University of Texas Health Science Center, San Antonio, have found increased activity in the cortex accompanied by decreases in limbic regions in patients who responded to either the popular antidepressant fluoxetine or to a placebo. They propose that this pattern of changes may be necessary for therapeutic response. However, patients who responded to fluoxetine also experienced unique changes in lower areas -- brainstem, striatum and hippocampus -- thought to confer additional advantage in sustaining the response long term and preventing relapse. The researchers report on their Positron Emission Tomography (PET scan) study in the May 2002 American Journal of Psychiatry. "Our findings do not support the notion that antidepressants work merely via a placebo effect," cautioned Mayberg, who has since moved to the Rotman Research Institute at the University of Toronto. "Patients on active medication who failed to improve did not sustain the brainstem, striatal and hippocampus changes unique to antidepressant responders."

In the randomized, double blind trial, 17 middle-aged men, hospitalized for unipolar depression, received either fluoxetine or placebo for 6 weeks. Rating scales revealed that 4 of the men responded to placebo and another 4 showed comparable improvement with the active medication. Nine patients failed to get better.

"Treatment with placebo is not absence of treatment, just absence of active medication," note the researchers, citing possible therapeutic benefits of a change in environment and the supportive, therapeutic milieu of an inpatient psychiatric ward.

PET scans traced the destination of a radioactive form of glucose - the brain's fuel - to detect brain activity patterns. After 6 weeks, brains of men who responded to either treatment showed "remarkable concordance:" Activity increased in prefrontal cortex, posterior cingulate, premotor, parietal cortex, and posterior insula. Activity decreased in subgenual cingulate, parahippocampus, thalamus and hypothalamus.

Men who responded to fluoxetine, in addition, showed changes in certain lower brain areas -- brainstem, hippocampus, striatum and anterior insula. Brain areas activated in the fluoxetine responders were also somewhat larger. The brain stem and hippocampus appear to have important input in sustaining the cortical/limbic changes, suggest the researchers, who note that absence of changes in these lower brain areas in placebo responders may render them at higher risk for relapse, which several previous clinical studies have shown.

Although both placebo and antidepressant responders showed increased activity in the posterior cingulate (see graphic) at 6 weeks, this change had already occurred in placebo responders at 1 week. Together with other evidence, this suggests that the ability to increase activity in the posterior cingulate may be an early indicator of a brain's capacity to change and respond to treatment, says Mayberg. Medications that take a "bottom up" approach or non-drug, cognitive "top-down" interventions should work equally well. However, a need for progressively more aggressive treatments could signal "poor adaptive capacity" in the cortex/limbic network found to change in responders, say the researchers.

Also participating in the study were: J. Arturo Silva, M.D., Steven Brannan, M.D., Janet Tekell, M.D., Roderick Mahurin, Ph.D., Scott McGinnis, Paul Jerabek, Ph.D. In addition to an NIMH grant, the study was also supported by a grant from Eli Lilly and Company.

The National Institute of Mental Health (NIMH) is part of the National Institutes of Health (NIH), the Federal Government's primary agency for biomedical and behavioral research. NIH is a component of the U.S. Department of Health and Human Services.


Story Source:

The above story is based on materials provided by NIH/National Institute Of Mental Health. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Institute Of Mental Health. "Placebo, Antidepressant May Lift Depression Via Common Mechanism." ScienceDaily. ScienceDaily, 2 May 2002. <www.sciencedaily.com/releases/2002/05/020501072456.htm>.
NIH/National Institute Of Mental Health. (2002, May 2). Placebo, Antidepressant May Lift Depression Via Common Mechanism. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2002/05/020501072456.htm
NIH/National Institute Of Mental Health. "Placebo, Antidepressant May Lift Depression Via Common Mechanism." ScienceDaily. www.sciencedaily.com/releases/2002/05/020501072456.htm (accessed September 1, 2014).

Share This




More Mind & Brain News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Coffee Then Napping: The (New) Key To Alertness

Coffee Then Napping: The (New) Key To Alertness

Newsy (Aug. 30, 2014) — Researchers say having a cup of coffee then taking a nap is more effective than a nap or coffee alone. Video provided by Newsy
Powered by NewsLook.com
Young Entrepreneurs Get $100,000, If They Quit School

Young Entrepreneurs Get $100,000, If They Quit School

AFP (Aug. 29, 2014) — Twenty college-age students are getting 100,000 dollars from a Silicon Valley leader and a chance to live in San Francisco in order to work on the start-up project of their dreams, but they have to quit school first. Duration: 02:20 Video provided by AFP
Powered by NewsLook.com
Baby Babbling Might Lead To Faster Language Development

Baby Babbling Might Lead To Faster Language Development

Newsy (Aug. 29, 2014) — A new study suggests babies develop language skills more quickly if their parents imitate the babies' sounds and expressions and talk to them often. Video provided by Newsy
Powered by NewsLook.com
Electrical Stimulation Boosts Brain Function, Study Says

Electrical Stimulation Boosts Brain Function, Study Says

Newsy (Aug. 29, 2014) — Researchers found an improvement in memory and learning function in subjects who received electric pulses to their brains. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins